Recent advances in metabonomics.
- Author:
Guo-Wang XU
1
;
Xin LU
;
Sheng-Li YANG
Author Information
1. Metabonomics Research Center, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China. xugw@dicp.ac.cn
- Publication Type:Editorial
- MeSH:
Biomarkers;
Drug Discovery;
Metabolome;
Metabolomics;
trends
- From:
Acta Academiae Medicinae Sinicae
2007;29(6):701-711
- CountryChina
- Language:Chinese
-
Abstract:
Metabonomics (or metabolomics) aims at the comprehensive and quantitative analysis of the wide arrays of metabolites in biological samples. Metabonomics has been labeled as one of the new" -omics" joining genomics, transcriptomics, and proteomics as a science employed toward the understanding of global systems biology. It has been widely applied in many research areas including drug toxicology, biomarker discovery, functional genomics, and molecular pathology etc. The comprehensive analysis of the metabonome is particularly challenging due to the diverse chemical natures of metabolites. Metabonomics investigations require special approaches for sample preparation, data-rich analytical chemical measurements, and information mining. The outputs from a metabonomics study allow sample classification, biomarker discovery, and interpretation of the reasons for classification information. This review focuses on the currently new advances in various technical platforms of metabonomics and its applications in drug discovery and development, disease biomarker identification, plant and microbe related fields.
